New technique improves immune response and safety of hepatitis E vaccine
Hepatitis E, a viral infection which attacks the liver, is contracted by around 20 million people each year and results in 57,000 deaths annually. Although a vaccine has been available in China since 2011, it has yet to gain worldwide approval due to a lack of detailed safety data.
Now, a group of researchers, led by Guangjun Nie of the National Center for Nanoscience and Technology in Beijing, has found a way of delivering the vaccine using gold-nanoparticles, which could lead to safer and more effective protection from infection.
This article provides a link to coverage by Chemistry World.
Thanks for using Education in Chemistry. You can view one Education in Chemistry article per month as a visitor.
Registration is open to all teachers and technicians at secondary schools, colleges and teacher training institutions in the UK and Ireland.
Get all this, plus much more:
Already a Teach Chemistry member? Sign in now.
Not eligible for Teach Chemistry? Sign up for a personal account instead, or you can also access all our resources with Royal Society of Chemistry membership.